Pathophysiology of perinatal asphyxia: Can we predict and improve individual outcomes?

EPMA Journal

Volumn 2, Issue 2, 2011, Pages 211-230

  Morales, Paola ^a   Bustamante, Diego ^a   Espina Marchant, Pablo ^a   Neira Peña, Tanya ^a   Gutiérrez Hernández, Manuel A ^a   Allende Castro, Camilo ^a   Rojas Mancilla, Edgardo ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Hypoxia ischemia; Neonatal; Personalised treatments; Predictive diagnostic; Sequelae

Indexed keywords

2 IMINOBIOTIN; ACETYLCYSTEINE; ADENOSINE DIPHOSPHATE RIBOSE; ALLOPURINOL; APOMORPHINE; BIOLOGICAL MARKER; BUMETANIDE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ETIRACETAM; GLUTAMIC ACID; I KAPPA B; INDOMETACIN; MAGNESIUM SULFATE; MELATONIN; MEMANTINE; MINOCYCLINE; NECROSTATIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE SYNTHASE INHIBITOR; PHENOBARBITAL; POLYPHENOL; PROMEGRANATE POLYPHENOL; STATINE DERIVATIVE; TOPIRAMATE; UNCLASSIFIED DRUG; XENON;

ATTENTION DEFICIT DISORDER; CALCIUM HOMEOSTASIS; CELL DEATH; DOPAMINERGIC SYSTEM; DRUG INHIBITION; ENCEPHALITIS; ENERGY; HUMAN; HYPOTHERMIA; INCIDENCE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL ASPHYXIA; PERINATAL CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 79961085759     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-011-0100-3     Document Type: Review

References (315)

1. Herrera-Marschitz M, Morales P, Leyton L, Bustamante D, Klawitter V, Espina-Marchant P, et al. Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins. Neurotox Res. 2011; 19: 603-27.
2. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ. 1999; 319: 1054-9.
3. American College of Obstetrics and Gynecology., Task Force on Neonatal Encephalopathy and Cerebral Palsy., American Academy of Pediatrics. Neonatal Encephalopathy and Cerebral Palsy: Defining the Pathogenesis and Pathophysiology. Edited by Washington, DC, American College of Obstetricians and Gynecologists, 2003.
4. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976; 33: 696-705.
5. Leuthner SR, Das UG. Low Apgar scores and the definition of birth asphyxia. Pediatr Clin North Am. 2004; 51: 737-45.
6. Berger R, Garnier Y. Perinatal brain injury. J Perinat Med. 2000; 28: 261-85.
7. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev. 2001; 7: 56-64.
8. Vannucci SJ, Hagberg H. Hypoxia-ischemia in the immature brain. J Exp Biol. 2004; 207: 3149-54.
9. Low JA, Robertson DM, Simpson LL. Temporal relationships of neuropathologic conditions caused by perinatal asphyxia. Am J Obstet Gynecol. 1989; 160: 608-14.
10. de Haan M, Wyatt JS, Roth S, Vargha-Khadem F, Gadian D, Mishkin M. Brain and cognitive-behavioural development after asphyxia at term birth. Dev Sci. 2006; 9: 350-8.
11. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010; 86: 329-38.
12. Lawn J, Shibuya K, Stein C. No cry at birth: global estimates of intrapartum stillbirths and intrapartum-related neonatal deaths. Bull World Health Organ. 2005; 83: 409-17.
13. Lawn JE, Kerber K, Enweronu-Laryea C, Cousens S. 3. 6 million neonatal deaths-what is progressing and what is not? Semin Perinatol. 2010; 34: 371-86.
14. Wall SN, Lee AC, Carlo W, Goldenberg R, Niermeyer S, Darmstadt GL, et al. Reducing intrapartum-related neonatal deaths in low- and middle-income countries-what works? Semin Perinatol. 2010; 34: 395-407.
15. Prechtl HF, Einspieler C, Cioni G, Bos AF, Ferrari F, Sontheimer D. An early marker for neurological deficits after perinatal brain lesions. Lancet. 1997; 349: 1361-3.
16. Ferrari F, Todeschini A, Guidotti I, Martinez-Biarge M, Roversi MF, Berardi A, et al. General movements in full-term infants with perinatal asphyxia are related to basal ganglia and thalamic lesions. J Pediatr. 2011; 158: 904-11.
17. Martinez-Biarge M, Diez-Sebastian J, Rutherford MA, Cowan FM. Outcomes after central grey matter injury in term perinatal hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010; 86: 675-82.
18. Cowan F, Rutherford M, Groenendaal F, Eken P, Mercuri E, Bydder GM, et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet. 2003; 361: 736-42.
19. Kumar A, Mittal R, Khanna HD, Basu S. Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics. 2008; 122: e722-7.
20. Karlsson M, Wiberg-Itzel E, Chakkarapani E, Blennow M, Winbladh B, Thoresen M. Lactate dehydrogenase predicts hypoxic ischaemic encephalopathy in newborn infants: a preliminary study. Acta Paediatr. 2010; 99: 1139-44.
21. Ramin SM, Gilstrap 3rd LC. Other factors/conditions associated with cerebral palsy. Semin Perinatol. 2000; 24: 196-9.
22. van Handel M, Swaab H, de Vries LS, Jongmans MJ. Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review. Eur J Pediatr. 2007; 166: 645-54.
23. Bjorkman ST, Miller SM, Rose SE, Burke C, Colditz PB. Seizures are associated with brain injury severity in a neonatal model of hypoxia-ischemia. Neuroscience. 2010; 166: 157-67.
24. Maneru C, Junque C, Salgado-Pineda P, Serra-Grabulosa JM, Bartres-Faz D, Ramirez-Ruiz B, et al. Corpus callosum atrophy in adolescents with antecedents of moderate perinatal asphyxia. Brain Inj. 2003; 17: 1003-9.
25. Maneru C, Junque C, Botet F, Tallada M, Guardia J. Neuropsychological long-term sequelae of perinatal asphyxia. Brain Inj. 2001; 15: 1029-39.
26. Odd DE, Lewis G, Whitelaw A, Gunnell D. Resuscitation at birth and cognition at 8 years of age: a cohort study. Lancet. 2009; 373: 1615-22.
27. Cannon TD, Yolken R, Buka S, Torrey EF. Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol Psychiatry. 2008; 64: 797-802.
28. Herrera-Marschitz M, Dell'Anna E, Andersson K, Lubec G. Is perinatal asphyxia a concurrent factor for the development of neuropsychiatric syndromes with clinical onset at late age stages? Rev Chil Neuro-Psiquiatr. 1999; 37: 108-16.
29. Sommer JU, Schmitt A, Heck M, Schaeffer EL, Fendt M, Zink M, et al. Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2010; 260 Suppl 2: S81-9.
30. Basovich SN. The role of hypoxia in mental development and in the treatment of mental disorders: a review. Biosci Trends. 2010; 4: 288-96.
31. Cannon TD, Rosso IM, Hollister JM, Bearden CE, Sanchez LE, Hadley T. A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr Bull. 2000; 26: 351-66.
32. Zornberg GL, Buka SL, Tsuang MT. Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am J Psychiatr. 2000; 157: 196-202.
33. Dilenge ME, Majnemer A, Shevell MI. Long-term developmental outcome of asphyxiated term neonates. J Child Neurol. 2001; 16: 781-92.
34. Robertson C, Finer N. Term infants with hypoxic-ischemic encephalopathy: outcome at 3. 5 years. Dev Med Child Neurol. 1985; 27: 473-84.
35. Robertson CM, Finer NN. Educational readiness of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Dev Behav Pediatr. 1988; 9: 298-306.
36. Barnett A, Mercuri E, Rutherford M, Haataja L, Frisone MF, Henderson S, et al. Neurological and perceptual-motor outcome at 5-6 years of age in children with neonatal encephalopathy: relationship with neonatal brain MRI. Neuropediatrics. 2002; 33: 242-8.
37. Marlow N, Budge H. Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2005; 90: F193-4.
38. Robertson CM, Finer NN, Grace MG. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr. 1989; 114: 753-60.
39. Wakuda T, Matsuzaki H, Suzuki K, Iwata Y, Shinmura C, Suda S, et al. Perinatal asphyxia reduces dentate granule cells and exacerbates methamphetamine-induced hyperlocomotion in adulthood. PLoS One. 2008; 3: e3648.
40. Weitzdoerfer R, Pollak A, Lubec B. Perinatal asphyxia in the rat has lifelong effects on morphology, cognitive functions, and behavior. Semin Perinatol. 2004; 28: 249-56.
41. Calvert JW, Zhang JH. Pathophysiology of an hypoxic-ischemic insult during the perinatal period. Neurol Res. 2005; 27: 246-60.
42. Simola N, Bustamante D, Pinna A, Pontis S, Morales P, Morelli M, et al. Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats. Exp Brain Res. 2008; 185: 595-601.
43. Morales P, Fiedler JL, Andres S, Berrios C, Huaiquin P, Bustamante D, et al. Plasticity of hippocampus following perinatal asphyxia: effects on postnatal apoptosis and neurogenesis. J Neurosci Res. 2008; 86: 2650-62.
44. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 1982; 11: 491-8.
45. Pasternak JF, Predey TA, Mikhael MA. Neonatal asphyxia: vulnerability of basal ganglia, thalamus, and brainstem. Pediatr Neurol. 1991; 7: 147-9.
46. Gunn AJ, Cook CJ, Williams CE, Johnston BM, Gluckman PD. Electrophysiological responses of the fetus to hypoxia and asphyxia. J Dev Physiol. 1991; 16: 147-53.
47. Pastuszko A. Metabolic responses of the dopaminergic system during hypoxia in newborn brain. Biochem Med Metabol Biol. 1994; 51: 1-15.
48. van Erp TG, Saleh PA, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T, et al. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatr. 2002; 159: 1514-20.
49. Miller SP, Ramaswamy V, Michelson D, Barkovich AJ, Holshouser B, Wycliffe N, et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr. 2005; 146: 453-60.
50. Barkovich AJ, Miller SP, Bartha A, Newton N, Hamrick SE, Mukherjee P, et al. MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol. 2006; 27: 533-47.
51. DeLong GR. Autism, amnesia, hippocampus, and learning. Neurosci Biobehav Rev. 1992; 16: 63-70.
52. Lou HC. Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy. Acta Paediatr. 1996; 85: 1266-71.
53. Rennie JM, Hagmann CF, Robertson NJ. Outcome after intrapartum hypoxic ischaemia at term. Semin Fetal Neonatal Med. 2007; 12: 398-407.
54. Johnston MV, Hoon Jr AH. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol. 2000; 15: 588-91.
55. Stone BS, Zhang J, Mack DW, Mori S, Martin LJ, Northington FJ. Delayed neural network degeneration after neonatal hypoxia-ischemia. Ann Neurol. 2008; 64: 535-46.
56. Lodygensky GA, West T, Moravec MD, Back SA, Dikranian K, Holtzman DM, et al. Diffusion characteristics associated with neuronal injury and glial activation following hypoxia-ischemia in the immature brain. Magn Reson Med. 2011; doi: 10. 1002/mrm. 22869.
57. Dell'Anna E, Chen Y, Engidawork E, Andersson K, Lubec G, Luthman J, et al. Delayed neuronal death following perinatal asphyxia in rat. Exp Brain Res. 1997; 115: 105-15.
58. Morales P, Reyes P, Klawitter V, Huaiquin P, Bustamante D, Fiedler J, et al. Effects of perinatal asphyxia on cell proliferation and neuronal phenotype evaluated with organotypic hippocampal cultures. Neuroscience. 2005; 135: 421-31.
59. Bjelke B, Andersson K, Ogren SO, Bolme P. Asphyctic lesion: proliferation of tyrosine hydroxylase-immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission. Brain Res. 1991; 543: 1-9.
60. Johansen FF, Sorensen T, Tonder N, Zimmer J, Diemer NH. Ultrastructure of neurons containing somatostatin in the dentate hilus of the rat hippocampus after cerebral ischaemia, and a note on their commissural connections. Neuropathol Appl Neurobiol. 1992; 18: 145-57.
61. Morales P, Simola N, Bustamante D, Lisboa F, Fiedler J, Gebicke-Haerter PJ, et al. Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats. Exp Brain Res. 2010; 202: 1-14.
62. Kohlhauser C, Kaehler S, Mosgoeller W, Singewald N, Kouvelas D, Prast H, et al. Histological changes and neurotransmitter levels three months following perinatal asphyxia in the rat. Life Sci. 1999; 64: 2109-24.
63. Hoeger H, Engidawork E, Stolzlechner D, Bubna-Littitz H, Lubec B. Long-term effect of moderate and profound hypothermia on morphology, neurological, cognitive and behavioural functions in a rat model of perinatal asphyxia. Amino Acids. 2006; 31: 385-96.
64. Iuvone L, Geloso MC, Dell'Anna E. Changes in open field behavior, spatial memory, and hippocampal parvalbumin immunoreactivity following enrichment in rats exposed to neonatal anoxia. Exp Neurol. 1996; 139: 25-33.
65. Hoeger H, Engelmann M, Bernert G, Seidl R, Bubna-Littitz H, Mosgoeller W, et al. Long term neurological and behavioral effects of graded perinatal asphyxia in the rat. Life Sci. 2000; 66: 947-62.
66. Dell'Anna ME, Calzolari S, Molinari M, Iuvone L, Calimici R. Neonatal anoxia induces transitory hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. Behav Brain Res. 1991; 45: 125-34.
67. Lubec B, Chiappe-Gutierrez M, Hoeger H, Kitzmueller E, Lubec G. Glucose transporters, hexokinase, and phosphofructokinase in brain of rats with perinatal asphyxia. Pediatr Res. 2000; 47: 84-8.
68. Seidl R, Stockler-Ipsiroglu S, Rolinski B, Kohlhauser C, Herkner KR, Lubec B, et al. Energy metabolism in graded perinatal asphyxia of the rat. Life Sci. 2000; 67: 421-35.
69. Herrera-Marschitz M, Morales P, Leyton L, Bustamante D, Klawitter V, Espina-Marchant P, et al. Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins. Neurotox Res. 2011; 19: 603-27.
70. Chen Y, Engidawork E, Loidl F, Dell'Anna E, Goiny M, Lubec G, et al. Short- and long-term effects of perinatal asphyxia on monoamine, amino acid and glycolysis product levels measured in the basal ganglia of the rat. Brain Res Dev Brain Res. 1997; 104: 19-30.
71. Dienel GA, Hertz L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia. 2005; 50: 362-88.
72. Engidawork E, Chen Y, Dell'Anna E, Goiny M, Lubec G, Ungerstedt U, et al. Effect of perinatal asphyxia on systemic and intracerebral pH and glycolysis metabolism in the rat. Exp Neurol. 1997; 145: 390-6.
73. Lubec B, Dell'Anna E, Fang-Kircher S, Marx M, Herrera-Marschitz M, Lubec G. Decrease of brain protein kinase C, protein kinase A, and cyclin-dependent kinase correlating with pH precedes neuronal death in neonatal asphyxia. J Investig Med. 1997; 45: 284-94.
74. Lubec B, Marx M, Herrera-Marschitz M, Labudova O, Hoeger H, Gille L, et al. Decrease of heart protein kinase C and cyclin-dependent kinase precedes death in perinatal asphyxia of the rat. FASEB J. 1997; 11: 482-92.
75. Aronowski J, Grotta JC, Waxham MN. Ischemia-induced translocation of Ca2+/calmodulin-dependent protein kinase II: potential role in neuronal damage. J Neurochem. 1992; 58: 1743-53.
76. Kretzschmar M, Glockner R, Klinger W. Glutathione levels in liver and brain of newborn rats: investigations of the influence of hypoxia and reoxidation on lipid peroxidation. Physiol Bohemoslov. 1990; 39: 257-60.
77. Hasegawa T. Anti-stress effect of beta-carotene. Ann N Y Acad Sci. 1993; 691: 281-3.
78. Ikeda T, Choi BH, Yee S, Murata Y, Quilligan EJ. Oxidative stress, brain white matter damage and intrauterine asphyxia in fetal lambs. Int J Dev Neurosci. 1999; 17: 1-14.
79. Tan S, Zhou F, Nielsen VG, Wang Z, Gladson CL, Parks DA. Increased injury following intermittent fetal hypoxia-reoxygenation is associated with increased free radical production in fetal rabbit brain. J Neuropathol Exp Neurol. 1999; 58: 972-81.
80. Capani F, Loidl CF, Aguirre F, Piehl L, Facorro G, Hager A, et al. Changes in reactive oxygen species (ROS) production in rat brain during global perinatal asphyxia: an ESR study. Brain Res. 2001; 914: 204-7.
81. Numagami Y, Zubrow AB, Mishra OP, Delivoria-Papadopoulos M. Lipid free radical generation and brain cell membrane alteration following nitric oxide synthase inhibition during cerebral hypoxia in the newborn piglet. J Neurochem. 1997; 69: 1542-7.
82. Berger R, Gjedde A, Heck J, Muller E, Krieglstein J, Jensen A. Extension of the 2-deoxyglucose method to the fetus in utero: theory and normal values for the cerebral glucose consumption in fetal guinea pigs. J Neurochem. 1994; 63: 271-9.
83. Dell'Anna E, Chen Y, Loidl F, Andersson K, Luthman J, Goiny M, et al. Short-term effects of perinatal asphyxia studied with Fos-immunocytochemistry and in vivo microdialysis in the rat. Exp Neurol. 1995; 131: 279-87.
84. Johnston MV, Fatemi A, Wilson MA, Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol. 2011; 10: 372-82.
85. Holopainen IE, Lauren HB. Glutamate signaling in the pathophysiology and therapy of prenatal insults. Pharmacol Biochem Behav. 2011; doi: 10. 1016/j. pbb. 2011. 03. 016.
86. Siesjö BK, Katsura K, Pahlmark K, Smith M-L. The multiples causes of ischemic brain damage: a speculative synthesis. In: Krieglstein J, Oberpichler-Schwenk H, editors. Pharmacology of cerebral ischemia. Stuttgart: Medpharm Scientific Publishers; 1992. p. 511-525.
87. Kirino T. Delayed neuronal death. Neuropathology. 2000; 20(Suppl): S95-7.
88. Chen Z, Kontonotas D, Friedmann D, Pitts-Kiefer A, Frederick JR, Siman R, et al. Developmental status of neurons selectively vulnerable to rapidly triggered post-ischemic caspase activation. Neurosci Lett. 2005; 376: 166-70.
89. Klawitter V, Morales P, Bustamante D, Goiny M, Herrera-Marschitz M. Plasticity of the central nervous system (CNS) following perinatal asphyxia: does nicotinamide provide neuroprotection? Amino Acids. 2006; 31: 377-84.
90. Klawitter V, Morales P, Bustamante D, Gomez-Urquijo S, Hokfelt T, Herrera-Marschitz M. Plasticity of basal ganglia neurocircuitries following perinatal asphyxia: effect of nicotinamide. Exp Brain Res. 2007; 180: 139-52.
91. Moroni F. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage. Curr Opin Pharmacol. 2008; 8: 96-103.
92. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969; 164: 719-21.
93. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984; 43: 1369-74.
94. McDonald JW, Johnston MV. Pharmacology of N-methyl-D-aspartate-induced brain injury in an in vivo perinatal rat model. Synapse. 1990; 6: 179-88.
95. Peeters LL, Sheldon RE, Jones Jr MD, Makowski EL, Meschia G. Blood flow to fetal organs as a function of arterial oxygen content. Am J Obstet Gynecol. 1979; 135: 637-46.
96. Jensen A, Berger R. Fetal circulatory responses to oxygen lack. J Dev Physiol. 1991; 16: 181-207.
97. Berger R, Garnier Y. Pathophysiology of perinatal brain damage. Brain Res Brain Res Rev. 1999; 30: 107-34.
98. Lou HC, Tweed WA, Davies JM. Preferential blood flow increase to the brain stem in moderate neonatal hypoxia: reversal by naloxone. Eur J Pediatr. 1985; 144: 225-7.
99. Gitto E, Reiter RJ, Karbownik M, Tan DX, Gitto P, Barberi S, et al. Causes of oxidative stress in the pre- and perinatal period. Biol Neonate. 2002; 81: 146-57.
100. Mizui T, Kinouchi H, Chan PH. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am J Physiol. 1992; 262: H313-7.
101. Dringen R. Glutathione metabolism and oxidative stress in neurodegeneration. Eur J Biochem. 2000; 267: 4903.
102. Dringen R, Pawlowski PG, Hirrlinger J. Peroxide detoxification by brain cells. J Neurosci Res. 2005; 79: 157-65.
103. McQuillen PS, Ferriero DM. Selective vulnerability in the developing central nervous system. Pediatr Neurol. 2004; 30: 227-35.
104. Jensen A, Garnier Y, Middelanis J, Berger R. Perinatal brain damage-from pathophysiology to prevention. Eur J Obstet Gynecol Reprod Biol. 2003; 110 Suppl 1: S70-9.
105. Erecinska M, Cherian S, Silver IA. Energy metabolism in mammalian brain during development. Prog Neurobiol. 2004; 73: 397-445.
106. Northington FJ, Zelaya ME, O'Riordan DP, Blomgren K, Flock DL, Hagberg H, et al. Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as "continuum" phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience. 2007; 149: 822-33.
107. Hagberg H, Mallard C, Rousset CI, Xiaoyang W. Apoptotic mechanisms in the immature brain: involvement of mitochondria. J Child Neurol. 2009; 24: 1141-6.
108. Ginet V, Puyal J, Clarke PG, Truttmann AC. Enhancement of autophagic flux after neonatal cerebral hypoxia-ischemia and its region-specific relationship to apoptotic mechanisms. Am J Pathol. 2009; 175: 1962-74.
109. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009; 16: 966-75.
110. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 1995; 92: 7162-6.
111. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000; 407: 802-9.
112. Kirino T, Tamura A, Sano K. Selective vulnerability of the hippocampus to ischemia-reversible and irreversible types of ischemic cell damage. Prog Brain Res. 1985; 63: 39-58.
113. Northington FJ, Ferriero DM, Graham EM, Traystman RJ, Martin LJ. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis. 2001; 8: 207-19.
114. Ness JM, Harvey CA, Strasser A, Bouillet P, Klocke BJ, Roth KA. Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Res. 2006; 1099: 150-9.
115. Chen J, Zhu RL, Nakayama M, Kawaguchi K, Jin K, Stetler RA, et al. Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J Neurochem. 1996; 67: 64-71.
116. Graham EM, Sheldon RA, Flock DL, Ferriero DM, Martin LJ, O'Riordan DP, et al. Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury. Neurobiol Dis. 2004; 17: 89-98.
117. Cheng Y, Black IB, DiCicco-Bloom E. Hippocampal granule neuron production and population size are regulated by levels of bFGF. Eur J Neurosci. 2002; 15: 3-12.
118. Golan H, Huleihel M. The effect of prenatal hypoxia on brain development: short- and long-term consequences demonstrated in rodent models. Dev Sci. 2006; 9: 338-49.
119. Ferrer I, Pozas E, Marti M, Blanco R, Planas AM. Methylazoxymethanol acetate-induced apoptosis in the external granule cell layer of the developing cerebellum of the rat is associated with strong c-Jun expression and formation of high molecular weight c-Jun complexes. J Neuropathol Exp Neurol. 1997; 56: 1-9.
120. Daval JL, Pourie G, Grojean S, Lievre V, Strazielle C, Blaise S, et al. Neonatal hypoxia triggers transient apoptosis followed by neurogenesis in the rat CA1 hippocampus. Pediatr Res. 2004; 55: 561-7.
121. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem. 2001; 276: 10191-8.
122. Fatemi A, Wilson MA, Johnston MV. Hypoxic-ischemic encephalopathy in the term infant. Clin Perinatol. 2009; 36: 835-58. vii.
123. Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 1988; 451: 205-12.
124. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988; 1: 623-34.
125. Chen Y, Herrera-Marschitz M, Bjelke B, Blum M, Gross J, Andersson K. Perinatal asphyxia-induced changes in rat brain tyrosine hydroxylase-immunoreactive cell body number: effects of nicotine treatment. Neurosci Lett. 1997; 221: 77-80.
126. Johnston MV. Cellular alterations associated with perinatal asphyxia. Clin Invest Med. 1993; 16: 122-32.
127. Yeh TH, Hwang HM, Chen JJ, Wu T, Li AH, Wang HL. Glutamate transporter function of rat hippocampal astrocytes is impaired following the global ischemia. Neurobiol Dis. 2005; 18: 476-83.
128. Silverstein F, Johnston MV. Effects of hypoxia-ischemia on monoamine metabolism in the immature brain. Ann Neurol. 1984; 15: 342-7.
129. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 1986; 19: 105-11.
130. Chen HL, Pistollato F, Hoeppner DJ, Ni HT, McKay RD, Panchision DM. Oxygen tension regulates survival and fate of mouse central nervous system precursors at multiple levels. Stem Cells. 2007; 25: 2291-301.
131. Riikonen RS, Kero PO, Simell OG. Excitatory amino acids in cerebrospinal fluid in neonatal asphyxia. Pediatr Neurol. 1992; 8: 37-40.
132. Hagberg H, Thornberg E, Blennow M, Kjellmer I, Lagercrantz H, Thiringer K, et al. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy. Acta Paediatr. 1993; 82: 925-9.
133. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994; 12: 529-40.
134. Guerguerian AM, Brambrink AM, Traystman RJ, Huganir RL, Martin LJ. Altered expression and phosphorylation of N-methyl-D-aspartate receptors in piglet striatum after hypoxia-ischemia. Brain Res Mol Brain Res. 2002; 104: 66-80.
135. Mueller-Burke D, Koehler RC, Martin LJ. Rapid NMDA receptor phosphorylation and oxidative stress precede striatal neurodegeneration after hypoxic ischemia in newborn piglets and are attenuated with hypothermia. Int J Dev Neurosci. 2008; 26: 67-76.
136. Sanchez RM, Koh S, Rio C, Wang C, Lamperti ED, Sharma D, et al. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci. 2001; 21: 8154-63.
137. Talos DM, Fishman RE, Park H, Folkerth RD, Follett PL, Volpe JJ, et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex. J Comp Neurol. 2006; 497: 42-60.
138. Beattie MS, Ferguson AR, Bresnahan JC. AMPA-receptor trafficking and injury-induced cell death. Eur J Neurosci. 2010; 32: 290-7.
139. Silverstein FS, Torke L, Barks J, Johnston MV. Hypoxia-ischemia produces focal disruption of glutamate receptors in developing brain. Brain Res. 1987; 431: 33-9.
140. McDonald JW, Silverstein FS, Johnston MV. MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol. 1987; 140: 359-61.
141. Ford LM, Sanberg PR, Norman AB, Fogelson MH. MK-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats. Arch Neurol. 1989; 46: 1090-6.
142. Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur J Neurosci. 2006; 23: 2611-22.
143. Bergles DE, Jahr CE. Synaptic activation of glutamate transporters in hippocampal astrocytes. Neuron. 1997; 19: 1297-308.
144. Carmignoto G. Reciprocal communication systems between astrocytes and neurones. Prog Neurobiol. 2000; 62: 561-81.
145. Domingues AM, Taylor M, Fern R. Glia as transmitter sources and sensors in health and disease. Neurochem Int. 2010; 57: 359-66.
146. Hamilton NB, Attwell D. Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci. 2010; 11: 227-38.
147. Halassa MM, Haydon PG. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol. 2010; 72: 335-55.
148. Frizzo JK, Cardoso MP, de Assis AM, Perry ML, Volonte C, Frizzo ME. Effects of acute perinatal asphyxia in the rat hippocampus. Cell Mol Neurobiol. 2010; 30: 683-92.
149. Jantzie LL, Cheung PY, Johnson ST, Bigam DL, Todd KG. Cerebral amino acid profiles after hypoxia-reoxygenation and N-acetylcysteine treatment in the newborn piglet. Neonatology. 2010; 97: 195-203.
150. Dallas M, Boycott HE, Atkinson L, Miller A, Boyle JP, Pearson HA, et al. Hypoxia suppresses glutamate transport in astrocytes. J Neurosci. 2007; 27: 3946-55.
151. van den Heuvel DM, Pasterkamp RJ. Getting connected in the dopamine system. Prog Neurobiol. 2008; 85: 75-93.
152. Broderick PA, Gibson GE. Dopamine and serotonin in rat striatum during in vivo hypoxic-hypoxia. Metab Brain Dis. 1989; 4: 143-53.
153. Akiyama Y, Ito A, Koshimura K, Ohue T, Yamagata S, Miwa S, et al. Effects of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo in rat striatum. Brain Res. 1991; 561: 120-7.
154. Akiyama Y, Koshimura K, Ohue T, Lee K, Miwa S, Yamagata S, et al. Effects of hypoxia on the activity of the dopaminergic neuron system in the rat striatum as studied by in vivo brain microdialysis. J Neurochem. 1991; 57: 997-1002.
155. Knapp AG, Dowling JE. Dopamine enhances excitatory amino acid-gated conductances in cultured retinal horizontal cells. Nature. 1987; 325: 437-9.
156. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem. 1988; 51: 1455-64.
157. Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res. 1988; 23: 143-50.
158. Goplerud JM, Mishra OP, Delivoria-Papadopoulos M. Brain cell membrane dysfunction following acute asphyxia in newborn piglets. Biol Neonate. 1992; 61: 33-41.
159. Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 1990; 4: 2587-97.
160. Olano M, Song D, Murphy S, Wilson DF, Pastuszko A. Relationships of dopamine, cortical oxygen pressure, and hydroxyl radicals in brain of newborn piglets during hypoxia and posthypoxic recovery. J Neurochem. 1995; 65: 1205-12.
161. Halliwell B, Gutteridge JM. The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med. 1985; 8: 89-193.
162. Gross J, Andersson K, Chen Y, Muller I, Andreeva N, Herrera-Marschitz M. Effect of perinatal asphyxia on tyrosine hydroxylase and D2 and D1 dopamine receptor mRNA levels expressed during early postnatal development in rat brain. Brain Res Mol Brain Res. 2005; 134: 275-81.
163. Morales P, Klawitter V, Johansson S, Huaiquin P, Barros VG, Avalos AM, et al. Perinatal asphyxia impairs connectivity and dopamine neurite branching in organotypic triple culture from rat substantia nigra, neostriatum and neocortex. Neurosci Lett. 2003; 348: 175-9.
164. Strackx E, van den Hove DL, Steinbusch HP, Steinbusch HW, Vles JS, Blanco CE, et al. A combined behavioral and morphological study on the effects of fetal asphyxia on the nigrostriatal dopaminergic system in adult rats. Exp Neurol. 2008; 211: 413-22.
165. Derijck AA, van Erp S, Pasterkamp RJ. Semaphorin signaling: molecular switches at the midline. Trends Cell Biol. 2010; 20: 568-76.
166. Seiger A, Olson L. Late prenatal ontogeny of central monoamine neurons in the rat: Fluorescence histochemical observations. Z Anat Entwicklungsgesch. 1973; 140: 281-318.
167. Antonopoulos J, Dori I, Dinopoulos A, Chiotelli M, Parnavelas JG. Postnatal development of the dopaminergic system of the striatum in the rat. Neuroscience. 2002; 110: 245-56.
168. Pasterkamp RJ, Kolodkin AL. Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol. 2003; 13: 79-89.
169. Herrera-Marschitz M, Kohlhauser C, Gomez-Urquijo S, Ubink R, Goiny M, Hokfelt T. Excitatory amino acids, monoamine, and nitric oxide synthase systems in organotypic cultures: biochemical and immunohistochemical analysis. Amino Acids. 2000; 19: 33-43.
170. Gomez-Urquijo SM, Hokfelt T, Ubink R, Lubec G, Herrera-Marschitz M. Neurocircuitries of the basal ganglia studied in organotypic cultures: focus on tyrosine hydroxylase, nitric oxide synthase and neuropeptide immunocytochemistry. Neuroscience. 1999; 94: 1133-51.
171. Sanders MJ, Wiltgen BJ, Fanselow MS. The place of the hippocampus in fear conditioning. Eur J Pharmacol. 2003; 463: 217-23.
172. Kalisch R, Schubert M, Jacob W, Kessler MS, Hemauer R, Wigger A, et al. Anxiety and hippocampus volume in the rat. Neuropsychopharmacology. 2006; 31: 925-32.
173. Klawitter V, Morales P, Johansson S, Bustamante D, Goiny M, Gross J, et al. Effects of perinatal asphyxia on cell survival, neuronal phenotype and neurite growth evaluated with organotypic triple cultures. Amino Acids. 2005; 28: 149-55.
174. Ziebell JM, Morganti-Kossmann MC. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics. 2010; 7: 22-30.
175. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, et al. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol. 2007; 190: 28-33.
176. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010; 140: 918-34.
177. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007; 117: 289-96.
178. Greaves DR, Gordon S. Macrophage-specific gene expression: current paradigms and future challenges. Int J Hematol. 2002; 76: 6-15.
179. Monif M, Burnstock G, Williams DA. Microglia: proliferation and activation driven by the P2X7 receptor. Int J Biochem Cell Biol. 2010; 42: 1753-6.
180. Harry GJ, Kraft AD. Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol. 2008; 4: 1265-77.
181. Giulian D, Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke. 1993; 24: I84-90.
182. Hermoso MA, Cidlowski JA. Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life. 2003; 55: 497-504.
183. Clemens JA, Stephenson DT, Yin T, Smalstig EB, Panetta JA, Little SP. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats. Stroke. 1998; 29: 677-82.
184. Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J, et al. IKK mediates ischemia-induced neuronal death. Nat Med. 2005; 11: 1322-9.
185. Lubec B, Labudova O, Hoeger H, Kirchner L, Lubec G. Expression of transcription factors in the brain of rats with perinatal asphyxia. Biol Neonate. 2002; 81: 266-78.
186. Buller KM, Carty ML, Reinebrant HE, Wixey JA. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate? J Neurosci Res. 2009; 87: 599-608.
187. Battista D, Ferrari CC, Gage FH, Pitossi FJ. Neurogenic niche modulation by activated microglia: transforming growth factor beta increases neurogenesis in the adult dentate gyrus. Eur J Neurosci. 2006; 23: 83-93.
188. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007; 10: 1387-94.
189. Girard S, Kadhim H, Roy M, Lavoie K, Brochu ME, Larouche A, et al. Role of perinatal inflammation in cerebral palsy. Pediatr Neurol. 2009; 40: 168-74.
190. Foster-Barber A, Dickens B, Ferriero DM. Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome. Dev Neurosci. 2001; 23: 213-8.
191. Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2006; 28: 178-82.
192. Deng W. Neurobiology of injury to the developing brain. Nat Rev Neurol. 2010; 6: 328-36.
193. Alano CC, Ying W, Swanson RA. Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem. 2004; 279: 18895-902.
194. Leppard JB, Dong Z, Mackey ZB, Tomkinson AE. Physical and functional interaction between DNA ligase IIIalpha and poly(ADP-Ribose) polymerase 1 in DNA single-strand break repair. Mol Cell Biol. 2003; 23: 5919-27.
195. Mishra OP, Akhter W, Ashraf QM, Delivoria-Papadopoulos M. Hypoxia-induced modification of poly (ADP-ribose) polymerase and dna polymerase beta activity in cerebral cortical nuclei of newborn piglets: role of nitric oxide. Neuroscience. 2003; 119: 1023-32.
196. Wilson SH. Mammalian base excision repair and DNA polymerase beta. Mutat Res. 1998; 407: 203-15.
197. Chiappe-Gutierrez M, Kitzmueller E, Labudova O, Fuerst G, Hoeger H, Hardmeier R, et al. mRNA levels of the hypoxia inducible factor (HIF-1) and DNA repair genes in perinatal asphyxia of the rat. Life Sci. 1998; 63: 1157-67.
198. Sung P, Bailly V, Weber C, Thompson LH, Prakash L, Prakash S. Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature. 1993; 365: 852-5.
199. de Murcia G, Menissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci. 1994; 19: 172-6.
200. Hortobagyi T, Gorlach C, Benyo Z, Lacza Z, Hortobagyi S, Wahl M, et al. Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide. Neuroscience. 2003; 121: 983-90.
201. Altmeyer M, Hottiger MO. Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging. Aging (Albany NY). 2009; 1: 458-69.
202. Poitras MF, Koh DW, Yu SW, Andrabi SA, Mandir AS, Poirier GG, et al. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain. Neuroscience. 2007; 148: 198-211.
203. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010; 10: 293-301.
204. Haile WB, Echeverry R, Wu F, Guzman J, An J, Wu J, et al. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death. Neuroscience. 2010; 171: 1256-64.
205. D'Amours D, Sallmann FR, Dixit VM, Poirier GG. Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci. 2001; 114: 3771-8.
206. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays. 2001; 23: 795-806.
207. Lorek A, Takei Y, Cady EB, Wyatt JS, Penrice J, Edwards AD, et al. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res. 1994; 36: 699-706.
208. Yoles E, Zarchin N, Zurovsky Y, Mayevsky A. Metabolic and ionic responses to global brain ischemia in the newborn dog in vivo: II. Post-natal age aspects. Neurol Res. 2000; 22: 623-9.
209. Mayevsky A, Rogatsky GG. Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies. Am J Physiol Cell Physiol. 2007; 292: C615-40.
210. Szabo C. Cardioprotective effects of poly(ADP-ribose) polymerase inhibition. Pharmacol Res. 2005; 52: 34-43.
211. Grupp IL, Jackson TM, Hake P, Grupp G, Szabo C. Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts. J Mol Cell Cardiol. 1999; 31: 297-303.
212. Yagita Y, Kitagawa K, Ohtsuki T, Takasawa K, Miyata T, Okano H, et al. Neurogenesis by progenitor cells in the ischemic adult rat hippocampus. Stroke. 2001; 32: 1890-6.
213. Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell. 2002; 110: 429-41.
214. Kee NJ, Preston E, Wojtowicz JM. Enhanced neurogenesis after transient global ischemia in the dentate gyrus of the rat. Exp Brain Res. 2001; 136: 313-20.
215. Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci USA. 2001; 98: 4710-5.
216. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell. 2008; 132: 645-60.
217. Bartley J, Soltau T, Wimborne H, Kim S, Martin-Studdard A, Hess D, et al. BrdU-positive cells in the neonatal mouse hippocampus following hypoxic-ischemic brain injury. BMC Neurosci. 2005; 6: 15.
218. Fagel DM, Ganat Y, Silbereis J, Ebbitt T, Stewart W, Zhang H, et al. Cortical neurogenesis enhanced by chronic perinatal hypoxia. Exp Neurol. 2006; 199: 77-91.
219. Moonen HJ, Geraets L, Vaarhorst A, Bast A, Wouters EF, Hageman GJ. Theophylline prevents NAD+ depletion via PARP-1 inhibition in human pulmonary epithelial cells. Biochem Biophys Res Commun. 2005; 338: 1805-10.
220. Morales P, Huaiquin P, Bustamante D, Fiedler J, Herrera-Marschitz M. Perinatal asphyxia induces neurogenesis in hippocampus: an organotypic culture study. Neurotox Res. 2007; 12: 81-4.
221. Ong J, Plane JM, Parent JM, Silverstein FS. Hypoxic-ischemic injury stimulates subventricular zone proliferation and neurogenesis in the neonatal rat. Pediatr Res. 2005; 58: 600-6.
222. Plane JM, Liu R, Wang TW, Silverstein FS, Parent JM. Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol Dis. 2004; 16: 585-95.
223. Kokaia Z, Thored P, Arvidsson A, Lindvall O. Regulation of stroke-induced neurogenesis in adult brain-recent scientific progress. Cereb Cortex. 2006; 16 Suppl 1: i162-7.
224. Lichtenwalner RJ, Parent JM. Adult neurogenesis and the ischemic forebrain. J Cereb Blood Flow Metab. 2006; 26: 1-20.
225. Richardson RM, Sun D, Bullock MR. Neurogenesis after traumatic brain injury. Neurosurg Clin N Am. 2007; 18: 169-81. xi.
226. Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci. 1997; 17: 5046-61.
227. Bedard A, Gravel C, Parent A. Chemical characterization of newly generated neurons in the striatum of adult primates. Exp Brain Res. 2006; 170: 501-12.
228. Collin T, Arvidsson A, Kokaia Z, Lindvall O. Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury. Exp Neurol. 2005; 195: 71-80.
229. Lemasson M, Saghatelyan A, Olivo-Marin JC, Lledo PM. Neonatal and adult neurogenesis provide two distinct populations of newborn neurons to the mouse olfactory bulb. J Neurosci. 2005; 25: 6816-25.
230. Takami K, Iwane M, Kiyota Y, Miyamoto M, Tsukuda R, Shiosaka S. Increase of basic fibroblast growth factor immunoreactivity and its mRNA level in rat brain following transient forebrain ischemia. Exp Brain Res. 1992; 90: 1-10.
231. Ganat Y, Soni S, Chacon M, Schwartz ML, Vaccarino FM. Chronic hypoxia up-regulates fibroblast growth factor ligands in the perinatal brain and induces fibroblast growth factor-responsive radial glial cells in the sub-ependymal zone. Neuroscience. 2002; 112: 977-91.
232. Mudo G, Bonomo A, Di Liberto V, Frinchi M, Fuxe K, Belluardo N. The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J Neural Transm. 2009; 116: 995-1005.
233. Suh SW, Aoyama K, Alano CC, Anderson CM, Hamby AM, Swanson RA. Zinc inhibits astrocyte glutamate uptake by activation of poly(ADP-ribose) polymerase-1. Mol Med. 2007; 13: 344-9.
234. Tsang M, Dawid IB. Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci STKE. 2004; 2004: pe17.
235. Tsuji L, Yamashita T, Kubo T, Madura T, Tanaka H, Hosokawa K, et al. FLRT3, a cell surface molecule containing LRR repeats and a FNIII domain, promotes neurite outgrowth. Biochem Biophys Res Commun. 2004; 313: 1086-91.
236. Grote HE, Hannan AJ. Regulators of adult neurogenesis in the healthy and diseased brain. Clin Exp Pharmacol Physiol. 2007; 34: 533-45.
237. Yang Z, You Y, Levison SW. Neonatal hypoxic/ischemic brain injury induces production of calretinin-expressing interneurons in the striatum. J Comp Neurol. 2008; 511: 19-33.
238. Hoglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci. 2004; 7: 726-35.
239. Cameron HA, McEwen BS, Gould E. Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus. J Neurosci. 1995; 15: 4687-92.
240. Brezun JM, Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience. 1999; 89: 999-1002.
241. Brezun JM, Daszuta A. Serotonin may stimulate granule cell proliferation in the adult hippocampus, as observed in rats grafted with foetal raphe neurons. Eur J Neurosci. 2000; 12: 391-6.
242. Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, et al. Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol. 2006; 197: 113-21.
243. van Kampen JM, Hagg T, Robertson HA. Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation. Eur J Neurosci. 2004; 19: 2377-87.
244. Hiramoto T, Kanda Y, Satoh Y, Takishima K, Watanabe Y. Dopamine D2 receptor stimulation promotes the proliferation of neural progenitor cells in adult mouse hippocampus. Neuroreport. 2007; 18: 659-64.
245. Goffin D, Ali AB, Rampersaud N, Harkavyi A, Fuchs C, Whitton PS, et al. Dopamine-dependent tuning of striatal inhibitory synaptogenesis. J Neurosci. 2010; 30: 2935-50.
246. Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, et al. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur J Pharmacol. 2009; 617: 33-40.
247. O'Keeffe GC, Barker RA, Caldwell MA. Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain. Cell Cycle. 2009; 8: 2888-94.
248. Reuss B, Unsicker K. Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells. Mol Cell Neurosci. 2000; 16: 781-92.
249. Ohta K, Kuno S, Inoue S, Ikeda E, Fujinami A, Ohta M. The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes. J Neurol Sci. 2010; 291: 12-6.
250. Ohta M, Mizuta I, Ohta K, Nishimura M, Mizuta E, Hayashi K, et al. Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes. Biochem Biophys Res Commun. 2000; 272: 18-22.
251. Guo H, Tang Z, Yu Y, Xu L, Jin G, Zhou J. Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures. Eur J Neurosci. 2002; 16: 1861-70.
252. Li A, Guo H, Luo X, Sheng J, Yang S, Yin Y, et al. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. FASEB J. 2006; 20: 1263-5.
253. Konrad K, Eickhoff SB. Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp. 2010; 31: 904-16.
254. Herrera-Marschitz M, Arbuthnott G, Ungerstedt U. The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond. Prog Neurobiol. 2010; 90: 176-89.
255. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke. 2008; 39: 2129-37.
256. Fan X, van Bel F. Pharmacological neuroprotection after perinatal asphyxia. J Matern Fetal Neonatal Med. 2010; 23 Suppl 3: 17-9.
257. Roka A, Azzopardi D. Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy. Early Hum Dev. 2010; 86: 361-7.
258. Kelen D, Robertson NJ. Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev. 2010; 86: 369-77.
259. Herrera-Marschitz M, Loidl CF, Andersson K, Ungerstedt U. Prevention of mortality induced by perinatal asphyxia: hypothermia or glutamate antagonism? Amino Acids. 1993; 5: 413-9.
260. Thoresen M, Bagenholm R, Loberg EM, Apricena F, Kjellmer I. Posthypoxic cooling of neonatal rats provides protection against brain injury. Arch Dis Child Fetal Neonatal Ed. 1996; 74: F3-9.
261. Engidawork E, Loidl F, Chen Y, Kohlhauser C, Stoeckler S, Dell'Anna E, et al. Comparison between hypothermia and glutamate antagonism treatments on the immediate outcome of perinatal asphyxia. Exp Brain Res. 2001; 138: 375-83.
262. Gunn AJ, Gunn TR. The 'pharmacology' of neuronal rescue with cerebral hypothermia. Early Hum Dev. 1998; 53: 19-35.
263. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, et al. Moderate hypothermia in neonatal encephalopathy: safety outcomes. Pediatr Neurol. 2005; 32: 18-24.
264. Gunn AJ, Bennet L. Is temperature important in delivery room resuscitation? Semin Neonatol. 2001; 6: 241-9.
265. Drury PP, Bennet L, Gunn AJ. Mechanisms of hypothermic neuroprotection. Semin Fetal Neonatal Med. 2010; 15: 287-92.
266. Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, et al. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun. 1992; 182: 593-9.
267. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005; 353: 1574-84.
268. Pfister RH, Soll RF. Hypothermia for the treatment of infants with hypoxic-ischemic encephalopathy. J Perinatol. 2010; 30(Suppl): S82-7.
269. Herrera-Marschitz M, Loidl CF, You ZB, Andersson K, Silveira R, O'Connor WT, et al. Neurocircuitry of the basal ganglia studied by monitoring neurotransmitter release. Effects of intracerebral and perinatal asphyctic lesions. Mol Neurobiol. 1994; 9: 171-82.
270. Meyn Jr DF, Ness J, Ambalavanan N, Carlo WA. Prophylactic phenobarbital and whole-body cooling for neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2010; 157: 334-6.
271. Barks JD, Liu YQ, Shangguan Y, Silverstein FS. Phenobarbital augments hypothermic neuroprotection. Pediatr Res. 2010; 67: 532-7.
272. Filippi L, Poggi C, la Marca G, Furlanetto S, Fiorini P, Cavallaro G, et al. Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study. J Pediatr. 2010; 157: 361-6.
273. Liu C, Lin N, Wu B, Qiu Y. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Res. 2009; 1282: 173-82.
274. Cilio MR, Ferriero DM. Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med. 2010; 15: 293-8.
275. Chakkarapani E, Dingley J, Liu X, Hoque N, Aquilina K, Porter H, et al. Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol. 2010; 68: 330-41.
276. Cetinkaya M, Alkan T, Ozyener F, Kafa IM, Kurt MA, Koksal N. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology. 2010; 99: 302-10.
277. Dzhala VI, Kuchibhotla KV, Glykys JC, Kahle KT, Swiercz WB, Feng G, et al. Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. J Neurosci. 2010; 30: 11745-61.
278. Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov. 2005; 4: 421-40.
279. Trucco C, Oliver FJ, de Murcia G, Menissier-de Murcia J. DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids Res. 1998; 26: 2644-9.
280. Schultz N, Lopez E, Saleh-Gohari N, Helleday T. Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination. Nucleic Acids Res. 2003; 31: 4959-64.
281. Geraets L, Moonen HJ, Wouters EF, Bast A, Hageman GJ. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations. Biochem Pharmacol. 2006; 72: 902-10.
282. Chong ZZ, Maiese K. Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways. Curr Neurovasc Res. 2008; 5: 159-70.
283. Maiese K, Chong ZZ, Hou J, Shang YC. The vitamin nicotinamide: translating nutrition into clinical care. Molecules. 2009; 14: 3446-85.
284. Sauve AA. NAD+ and vitamin B3: from metabolism to therapies. J Pharmacol Exp Ther. 2008; 324: 883-93.
285. Goffus AM, Anderson GD, Hoane M. Sustained delivery of nicotinamide limits cortical injury and improves functional recovery following traumatic brain injury. Oxid Med Cell Longev. 2010; 3: 145-52.
286. Yan Q, Briehl M, Crowley CL, Payne CM, Bernstein H, Bernstein C. The NAD+ precursors, nicotinic acid and nicotinamide upregulate glyceraldehyde-3-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase mRNA in Jurkat cells. Biochem Biophys Res Commun. 1999; 255: 133-6.
287. Wan FJ, Lin HC, Kang BH, Tseng CJ, Tung CS. D-amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment. Brain Res Bull. 1999; 50: 167-71.
288. Sakakibara Y, Mitha AP, Ogilvy CS, Maynard KI. Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar rats. Neurosci Lett. 2000; 281: 111-4.
289. Ducrocq S, Benjelloun N, Plotkine M, Ben-Ari Y, Charriaut-Marlangue C. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem. 2000; 74: 2504-11.
290. Zhang J, Steiner JP. Nitric oxide synthase, immunophilins and poly(ADP-ribose) synthetase: novel targets for the development of neuroprotective drugs. Neurol Res. 1995; 17: 285-8.
291. Bustamante D, Goiny M, Astrom G, Gross J, Andersson K, Herrera-Marschitz M. Nicotinamide prevents the long-term effects of perinatal asphyxia on basal ganglia monoamine systems in the rat. Exp Brain Res. 2003; 148: 227-32.
292. Bustamante D, Morales P, Pereyra JT, Goiny M, Herrera-Marschitz M. Nicotinamide prevents the effect of perinatal asphyxia on dopamine release evaluated with in vivo microdialysis 3 months after birth. Exp Brain Res. 2007; 177: 358-69.
293. Ferre S, Herrera-Marschitz M, Grabowska-Anden M, Casas M, Ungerstedt U, Anden NE. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. Eur J Pharmacol. 1991; 192: 31-7.
294. Khan M, Sekhon B, Jatana M, Giri S, Gilg AG, Sekhon C, et al. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res. 2004; 76: 519-27.
295. Pei Z, Pang SF, Cheung RT. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke. 2003; 34: 770-5.
296. Chaudhari T, McGuire W. Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev. 2008; CD006817.
297. West T, Atzeva M, Holtzman DM. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev Neurosci. 2007; 29: 363-72.
298. Northington FJ, Chavez-Valdez R, Graham EM, Razdan S, Gauda EB, Martin LJ. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab. 2011; 31: 178-89.
299. Zhong J, Zhao L, Du Y, Wei G, Yao WG, Lee WH. Delayed IGF-1 treatment reduced long-term hypoxia-ischemia-induced brain damage and improved behavior recovery of immature rats. Neurol Res. 2009; 31: 483-9.
300. Holtzman DM, Sheldon RA, Jaffe W, Cheng Y, Ferriero DM. Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol. 1996; 39: 114-22.
301. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci. 2000; 20: 5775-81.
302. Russell JC, Szuflita N, Khatri R, Laterra J, Hossain MA. Transgenic expression of human FGF-1 protects against hypoxic-ischemic injury in perinatal brain by intervening at caspase-XIAP signaling cascades. Neurobiol Dis. 2006; 22: 677-90.
303. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, et al. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res. 2010; 88: 1017-25.
304. Titomanlio L, Bouslama M, Verche VL, Dalous J, Kaindl AM, Tsenkina Y, et al. Implanted neurosphere-derived precursors promote recovery after neonatal excitotoxic brain injury. Stem Cells Dev. 2011; 20: 865-79.
305. Lee JA, Kim BI, Jo CH, Choi CW, Kim EK, Kim HS, et al. Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr Res. 2010; 67: 42-6.
306. Pimentel-Coelho PM, Mendez-Otero R. Cell therapy for neonatal hypoxic-ischemic encephalopathy. Stem Cells Dev. 2010; 19: 299-310.
307. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatr Res. 2010; 68: 419-22.
308. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun. 2011; doi: 10. 1016/j. bbi. 2011. 03. 021.
309. Yasuhara T, Hara K, Maki M, Mays RW, Deans RJ, Hess DC, et al. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab. 2008; 28: 1804-10.
310. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes. Brain Res Rev. 2009; 61: 1-13.
311. Qu R, Li Y, Gao Q, Shen L, Zhang J, Liu Z, et al. Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts. Neuropathology. 2007; 27: 355-63.
312. Leker RR, Lasri V, Chernoguz D. Growth factors improve neurogenesis and outcome after focal cerebral ischemia. J Neural Transm. 2009; 116: 1397-402.
313. Skaper SD. Neuronal growth-promoting and inhibitory cues in neuroprotection and neuroregeneration. Ann N Y Acad Sci. 2005; 1053: 376-85.
314. Pimentel-Coelho PM, Magalhaes ES, Lopes LM, deAzevedo LC, Santiago MF, Mendez-Otero R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev. 2010; 19: 351-8.
315. Cotten CM, Kurtzberg J, Song H, Goldstein R, Provenzale JM. Cordblood for hypoxic-ischemic encephalopathy; NCT00593242. http://clinicaltrials. gov/ct2/show/NCT00593242.